Primer sequences for RT-qPCR. by Hongyu Li (1332669)

Subjects:

miRNA 221 improved left ventricular contractile function in MIRI mice. by Hongyu Li (1332669)

Subjects:

<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. by Siyun Lee (17087351)

Intraperitoneal injection protocol for inhibitors (A), inhibitors DAS and Y27632 reduced intestinal permeability (B) and intestinal adult worm burden (C) of infected mice. by Wen Wen Zheng (17721404)

Subjects:

RipU^K60 decreases microtubule abundance at 48 hours post infiltration. by Rachel Hiles (20477573)

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. by Annaëlle Le Steunf (19838110)

Tissue repair Tregs are reduced in target tissues and lymphoid organs during acute <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

Tregs frequency is reduced in lymphoid and non-lymphoid target tissues during acute <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

T3SS induction reduces gentamicin susceptibility, but S10 expression predicts survival. by Justin Greene (306625)

Subjects:

Gentamicin treatment selects for surviving bacteria with reduced S10 expression in the mouse spleen. by Justin Greene (306625)

Subjects:

Increases in temperature for the two drill systems at different positions using different drilling procedures. The data in bold indicate the position where the highest mean tempera... by Marsel Ganeyev (21453399)

Subjects:

Inactivation of MnuA and 5′-NT reduced bacterial fitness and virulence of <i>M</i>. <i>bovis</i> PG45 in mammary glands. by Aga E. Gelgie (17661720)

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Reduced resistance and exacerbated lung inflammation in <i>ccr2</i>^-/- mice with <i>C</i>. <i>muridarum</i> respiratory infection. by Shuaini Yang (20670608)

Subjects: